Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jul;35(4):203-213.
doi: 10.1007/s40290-021-00397-6. Epub 2021 Aug 28.

The Emergency Use Authorization of Pharmaceuticals: History and Utility During the COVID-19 Pandemic

Allan Tran  1 , Theodore J Witek Jr  2   3
Affiliations
Review

The Emergency Use Authorization of Pharmaceuticals: History and Utility During the COVID-19 Pandemic

Allan Tran et al. Pharmaceut Med. 2021 Jul.

Abstract

The Emergency Use Authorization (EUA) originated in 2004 because of the need for emergency medical countermeasures (MCMs) against potential bioterrorist attacks. The EUA also proved useful in dealing with subsequent pandemics and has emerged as a critical regulatory pathway for therapeutics and vaccines throughout the Coronavirus Disease 2019 (COVID-19) pandemic. With the EUA process in the USA, we witnessed emergency authorizations, their expansions, as well as withdrawal of previously authorized products, which exemplifies the dynamic nature of scientific review of EUA products. EUAs proved vital for the first group of COVID-19 vaccines, including the temporary pause of one vaccine while emergency safety issues were evaluated. Although this review on the EUA is primarily focused on the USA, distinctions were made with other jurisdictions such as Europe and Canada with respect to the emergency authorizations of the vaccines. Finally, we discuss some important differences following EUA and formal new drug/vaccine application (NDA/BLA) approvals.

PubMed Disclaimer

Conflict of interest statement

We declare we have no conflicts of interest.

References

    1. Project BioShield Act of 2004, S 15, 108th Congress, (2004). https://www.congress.gov/bill/108th-congress/senate-bill/15. Accessed 14 May 2021.
    1. U.S Food & Drug Administration. MCM Emergency Use Authorities. U.S Food & Drug Administration; 2021. https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regula.... Accessed 14 May 2021.
    1. U.S Food & Drug Administration. Guidance Document: Emergency Use Authorization of Medical Products and Related Authorities. U.S Food & Drug Administration; 2017. https://www.fda.gov/media/97321/download. Accessed 21 July 2021.
    1. U.S Food & Drug Administration. Emergency Use Authorization—Archived Information. U.S Food & Drug Administration; 2021. https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regula.... Accessed 14 May 2021.
    1. Expanding Access to Investigational Therapies for HIV Infection and AIDS. National Academies Press; 1991. p. 1778. 10.17226/1778 - PubMed

MeSH terms